These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Azathioprine and steroids are not more effective in decreasing multiple sclerosis intra-blood-brain-barrier IgG synthesis than steroids alone. Staugaitis SM, Shapshak P, Myers LW, Ellison GW, Tourtellotte WW, Lee M. Ann Neurol; 1985 Sep; 18(3):356-7. PubMed ID: 2996418 [Abstract] [Full Text] [Related]
3. [The behavior of serum immunoglobulins in multiple sclerosis during anti-inflammatory therapy]. Paltrinieri E, Giovannucci M. Acta Neurol (Napoli); 1969 Sep; 24(4):613-25. PubMed ID: 4101181 [No Abstract] [Full Text] [Related]
15. The current status of multiple sclerosis intra-blood-brain-barrier IgG synthesis. Tourtellotte WW, Walsh MJ, Baumhefner RW, Staugaitis SM, Shapshak P. Ann N Y Acad Sci; 1984 Oct 15; 436():52-67. PubMed ID: 6398024 [Abstract] [Full Text] [Related]
17. Corticotropin is superior to corticosteroids in the treatment of MS. Poser CM. Arch Neurol; 1989 Sep 15; 46(9):946. PubMed ID: 2549925 [No Abstract] [Full Text] [Related]